Thermo Fisher Scientific Inc.
TMO | NYSE
$682.93
-$14.07 (-2.02%)
Nov 2, 2026, 10:32 AM ET · Market open
Market Data
Market Cap $252.51B
Enterprise Value $293.02B
Beta 0.88
Average Volume 2.17M
Shares Outstanding (Diluted) 371M
Shares Change YoY -1.85%
Institutional Ownership 91.40%
Exchange NYSE
ISIN US8835561023
Price Performance
Price Change 1M 4.3%
Price Change 3M 19.0%
Price Change 6M 47.6%
Price Change YTD 17.9%
Price Change 1Y 20.9%
Price Change 3Y 50.2%
Price Change 5Y 6.3%
1M CAGR (ann.) 7.0%
1Y CAGR (ann.) 25.3%
5Y CAGR (ann.) 2.9%
All-Time CAGR 15.2%
Valuation
PE Ratio 36.76
Forward PE 25.19
PEG Ratio 3.86
Forward PEG 3.30
PS Ratio 5.44
Forward PS 5.10
PB Ratio 4.71
P/FCF Ratio 33.93
P/Adj. FCF Ratio 34.31
P/OCF Ratio 27.66
EV/Sales 6.19
EV/EBIT 32.70
EV/EBITDA 26.07
EV/FCF 38.58
Earnings Yield 2.7%
FCF Yield 3.0%
Adj. FCF Yield 2.9%
Financial Health
Net Debt $35.31B
Total Debt $41.37B
Cash & Short-Term Investments $6.06B
Total Assets $114.23B
Current Ratio 1.81
Quick Ratio 1.41
Debt / Equity Ratio 0.76
Debt / EBITDA 3.68
Debt / FCF 5.45
OCF / Debt 0.23
Interest Coverage 5.54
Altman Z-Score 3.39
Piotroski F-Score 6
Margins & Profitability
Gross Profit Margin 41.4%
Operating Profit Margin 18.0%
EBITDA Margin 23.7%
Net Profit Margin 15.0%
FCF Margin 16.0%
Adj. FCF Margin 15.9%
SBC / Revenue 0.2%
SBC Impact (per share) -1.1%
Returns
Return on Assets 6.2%
Return on Equity 13.3%
Return on Invested Capital 7.5%
Return on Capital Employed 8.5%
Return on Tangible Assets 16.9%
Historical Growth (CAGR)
Revenue CAGR 3Y 2.9%
Revenue CAGR 5Y 3.9%
Revenue CAGR 10Y 10.2%
EPS CAGR 3Y 7.5%
EPS CAGR 5Y -2.5%
EPS CAGR 10Y 14.3%
FCF CAGR 3Y 5.1%
FCF CAGR 5Y -0.8%
FCF CAGR 10Y 10.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 13
EPS Growth Next 3Y 21.2%
Revenue Growth Next 3Y 6.5%
Earnings Date Feb 4, 2027
EPS Estimate (next Q) $7.13
EPS Growth Est (next Q) 8.5%
Revenue Est (next Q) $12.85B
Revenue Growth Est (next Q) 5.2%
Fair Value Estimates
Graham Number $251.29
Graham Upside -64.0%
Lynch Fair Value $94.80
Lynch Upside -86.4%
Price Target $694.27
Price Target Upside -0.4%
Cash Flow
Operating Cash Flow $9.32B
Free Cash Flow $7.6B
Adj. Free Cash Flow $7.51B
FCF Per Share $20.53
OCF Per Share $25.20
OCF/S Ratio 19.7%
Income Statement
Revenue $47.35B
Gross Profit $19.62B
Operating Income $8.52B
EBITDA $11.24B
Net Income $7.08B
EPS (Diluted) $18.96
Revenue / Employee $378.81K
Profit / Employee $56.66K
Employees 125,000
Dividends
Annual Dividend $1.84
Dividend Yield 0.26%
Payout Ratio 9.7%
FCF Payout Ratio 8.9%
Adj. FCF Payout Ratio 9.0%
Dividend Growth (YoY) 9.5%
Pay Frequency Quarterly
Ex-Dividend Date Sep 15, 2026
Add to Watchlist
Select watchlists to add or remove TMO